What is a Hormone Therapy SOAP Note Template and Why is it Required in Hormone Therapy Documentation?
A Hormone Therapy SOAP Note Template is a structured visit note for clinicians who start and monitor hormone treatment. It organizes patient goals, symptoms, therapy history, risk factors, lab results, and the plan into the Subjective, Objective, Assessment, and Plan format. Hormone care depends on trends across visits, so pre-charting that surfaces prior doses and labs helps each decision rest on the full history. The note also records the risk-benefit discussion behind each choice, which protects both the patient and the clinician.
Why Do Generic Templates Fail
Hormone Therapy SOAP Note Template cases involve:
Tracking symptom response against dose, route, and lab trends.
Documenting contraindications and risk factors before therapy starts.
Recording the risk-benefit discussion and informed consent.
Monitoring labs and safety markers specific to each therapy.
Following menopause, thyroid, testosterone, and gender-affirming regimens that each need different fields.
Coordinating care between endocrine and primary care teams.
Generic hormone therapy templates fail because they:
Offer one medication list with no fields for route, dose history, or response.
Leave out the review of personal and family cancer, clotting, and cardiovascular risk.
Treat the consent discussion as a checkbox.
Give no therapy-specific monitoring for estrogen, testosterone, or thyroid care.
Omit bone health, cardiometabolic, and screening status.
Essential for medico-legal documentation, especially in:
Informed consent and risk-benefit counseling
Contraindication and risk factor review
Monitoring labs and safety follow-up
Compounded or non-standard hormone use
Ensures compliance with documentation standards for diagnostic justification.
Hormone Therapy Structure: What to Include in Each Section
The following structure below reflects how Hormone Therapy SOAP Note Template evaluations are typically documented in practice.
Patient Information: Name, DOB, age/sex, MRN or patient ID, date of service, provider, credentials, primary care provider, visit type, care setting, referring provider, interpreter use.
Subjective: Reason for hormone therapy evaluation, patient goals and priorities, hormone-related symptoms, menstrual and reproductive history, menopause and perimenopause history, hypogonadism and androgen-related symptoms, gender-affirming therapy context, thyroid hormone context, current hormone therapy regimen, prior treatment history, medication and supplement history, risk factor review, family history, bone health, cardiometabolic health, cancer screening and preventive care, recent testing and specialist care, pertinent negatives.
Hormone Therapy Review of Systems: Hot flashes, night sweats, temperature intolerance, sleep disturbance, fatigue, mood changes, anxiety, depression, irritability, brain fog, libido change, sexual dysfunction, vaginal dryness, menstrual changes, breast symptoms, weight change, acne, hair changes, palpitations, chest pain, dyspnea, edema, headache, vision changes, neurologic symptoms, medication side effects and adherence issues.
Objective Examination: General appearance, head, eyes, ears, nose and throat, neck and thyroid, cardiovascular, pulmonary, breast or chest if assessed, abdomen, genitourinary, pelvic or prostate if assessed, skin and hair, musculoskeletal, neurologic, psychiatric.
Hormone Therapy Safety / Risk Assessment: Indication for hormone therapy, contraindications reviewed, personal and family cancer history, cardiovascular risk factors, thromboembolic risk factors, migraine with aura or neurologic risk, liver disease risk, blood pressure status, smoking or nicotine status, sleep apnea risk if relevant, fertility or pregnancy considerations, bone health considerations, medication interactions, route-specific risks and benefits, shared decision-making and informed consent discussion.
Therapy-Specific Monitoring: Estrogen therapy, progesterone or progestin therapy, testosterone therapy, antiandrogen therapy, thyroid hormone therapy, gender-affirming hormone therapy, compounded or non-standard hormone use, each with route, dose, response, side effects and monitoring needs.
Screening / Assessment Tools: Menopause symptom scale, hot flash diary, menstrual bleeding diary, PHQ-9, GAD-7, sexual function questionnaire, androgen deficiency symptom scale, gender dysphoria or affirmation goals assessment, ASCVD risk estimate, FRAX score, STOP-Bang if sleep apnea risk is relevant, medication adherence assessment.
Laboratory and Diagnostic Results: Sex hormone testing, thyroid testing, safety monitoring labs, cancer and preventive screening, cardiometabolic testing, imaging, prior records reviewed.
Assessment: Primary hormone-related diagnosis, indication for therapy, symptom severity and functional impact, response to current or prior therapy, side effects and safety concerns, adequacy of dosing, route, adherence and monitoring, lab interpretation in context, cardiovascular, thromboembolic, cancer, hepatic, bone, sleep apnea, fertility and mood-related risk considerations, preventive screening needs, shared decision-making and patient goals, need for initiation, continuation, dose adjustment, route change, taper, discontinuation, referral or further testing.
Plan: Hormone therapy plan, non-hormonal and adjunctive symptom management, monitoring plan, preventive screening plan, safety plan, fertility, pregnancy or contraception plan, lifestyle and risk reduction plan, medication and supplement review plan, referral and coordination, patient education on risks, benefits, alternatives and when to seek urgent care.
Follow-Up: Follow-up timeframe and purpose, symptom reassessment, side effect review, lab monitoring, dose adjustment, preventive screening completion, risk review, fertility or contraception follow-up, medication adherence review, referral follow-through.
Time Documentation: Total time spent, medication management time, risk-benefit counseling time, shared decision-making time, care coordination time, records review time, lab review time.
Billing Considerations: E/M level, preventive counseling codes if applicable, medication management codes if applicable, gender-affirming or endocrine care codes if applicable, basis for billing, primary hormone therapy or endocrine ICD-10 code, symptom, monitoring and preventive ICD-10 codes.
How to write Hormone Therapy SOAP Note Template with examples?
The template above shows the blank structure. Below is the same Hormone Therapy SOAP Note filled out with a realistic example, so you can see exactly how each section reads once it's completed with patient information, clinical findings, and a documented treatment plan.
Customizing Your Hormone Therapy SOAP Note Template to Match Your Documentation Style
The template gives you the structure. When you start using it with Marvix AI, the documentation itself adapts to how you write.
Marvix AI uses neural style transfer to learn from your existing notes, so you have custom made templates for all your workflows. It picks up your tone, your phrasing, and structure, then carries that into every note it generates.
If your notes are concise and point-wise, the output stays that way. If you write in a more narrative flow, it follows that instead. The note reads like something you wrote, not something you cleaned up.
This carries across clinical notes, after visit summaries, referral letters, IME reports and every other kind of documentation. And when you need a template for a new document type, Marvix AI builds it from your existing notes rather than starting from scratch.
Common Documentation Mistakes in Hormone Therapy Notes (and How to Avoid Them)
Recording doses without route or timing Estradiol patches and oral estradiol differ in risk and response, so the route matters. How to improve: Record the medication, route, dose, frequency, and timing.
Interpreting labs without timing A level drawn at the wrong point in the dosing cycle can look high or low for the wrong reason. How to improve: Note when the sample was drawn relative to the last dose.
Skipping the risk review Personal and family history of cancer, clotting, and cardiovascular disease shape whether and how therapy proceeds. How to improve: Document the contraindications reviewed and the reasoning for proceeding.
Treating consent as a signature A form alone does not show which risks, benefits, and alternatives were discussed. How to improve: Summarize the discussion and the patient's stated goals.
Leaving monitoring vague "Recheck labs" gives no timing and no marker. How to improve: State which labs and measurements are due and when.
Overlooking symptoms of over- or under-replacement Without a symptom review, a dose that looks correct on paper may be too high or too low. How to improve: Pair each lab result with the symptoms and exam findings.
Hormone Therapy Comparison: Generic Templates vs AI Scribes vs Marvix AI
A hormone therapy SOAP note template gives clinicians a consistent framework for documenting treatment decisions, but dose history and monitoring schedules still have to be managed manually. Most AI scribes are built for single-visit transcription and are not designed to track therapy across visits or connect lab results to symptoms. Marvix AI combines specialty-aware documentation with historical patient information, provider-specific writing styles, and structured workflows to produce complete hormone therapy notes that keep dose changes, lab trends, and the risk-benefit discussion easy to follow.
The Thyroid SOAP Note Template covers thyroid symptoms, lab review, and dose adjustment. It fits visits focused on thyroid hormone replacement.
Medication List Template
The Medication List Template records current drugs, doses, and allergies in one place. It supports the medication review that hormone therapy requires.
Medical Referral Letter Template
The Medical Referral Letter Template frames the reason for referral and the relevant findings. It helps when care moves to a specialist.
FAQs
What should a hormone therapy SOAP note include?
A hormone therapy SOAP note should include patient goals, hormone-related symptoms, the current and prior regimen, risk factors and contraindications, a focused exam, lab and screening results, an assessment of response and safety, and a plan covering dose, monitoring, and follow-up. The consent and risk-benefit discussion should be summarized.
How do you document the risk-benefit discussion for hormone therapy?
Record the indication, the benefits and risks reviewed, the alternatives offered, and the patient's goals and questions. Note route-specific considerations and the personal and family history that shaped the decision. State the decision reached and the plan to revisit it, so the reasoning is clear to anyone reading the chart later.
Which labs should be documented for hormone therapy monitoring?
The labs depend on the therapy. Examples include estradiol, testosterone, SHBG, LH and FSH, TSH and free T4, CBC with hematocrit, liver and renal function, potassium, lipids, and HbA1c. Record the date, the timing relative to the last dose, the result, and the action taken so trends stay visible.
How is menopause hormone therapy documented differently from testosterone or thyroid therapy?
The core note is the same, but the fields differ. Menopause notes track vasomotor and genitourinary symptoms, bleeding patterns, and the need for progesterone when a uterus is present. Testosterone notes track hematocrit and symptom response. Thyroid notes track TSH trends, adherence, and timing with food and supplements.
Which billing codes does a hormone therapy note support?
The note supports office visit E/M codes based on medical decision-making or total time. It can also support preventive counseling and medication management services when the required elements are documented. Recording total time, counseling and lab review time, and the basis for billing makes the claim easier to support.
General Medical DisclaimerThis content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Clinicians should use their professional judgment and follow applicable clinical guidelines when using any template.
2
Clinical Responsibility DisclaimerUse of this template does not replace independent clinical decision-making. The clinician remains fully responsible for the accuracy, completeness, and appropriateness of all documented information.
3
No Patient Relationship DisclaimerThis content does not establish a clinician–patient relationship. It is intended solely as a documentation reference for healthcare professionals.
4
Template Use DisclaimerThe templates provided are structural guides and may require modification based on specialty, patient context, and institutional requirements. They are not one-size-fits-all solutions.
5
Regulatory Compliance DisclaimerUsers are responsible for ensuring that documentation complies with local laws, licensing requirements, payer guidelines, and institutional policies.
6
Billing and Coding DisclaimerTemplates are not a substitute for proper coding knowledge. Clinicians must ensure that documentation meets requirements for E/M coding and reimbursement standards applicable in their region.
7
Data Privacy DisclaimerAny patient information documented using these templates must comply with applicable data protection regulations such as HIPAA or other regional privacy laws. Avoid including identifiable patient data in unsecured systems.
8
No Guarantee of Outcomes DisclaimerUse of these templates does not guarantee clinical outcomes, documentation acceptance, or reimbursement approval.
9
Third-Party Tools Disclaimer (Marvix AI)When using AI-assisted documentation tools such as Marvix AI, clinicians should review all generated content for accuracy and clinical appropriateness before finalizing records.
10
Jurisdictional Variation DisclaimerClinical documentation standards and legal requirements vary by country, state, and institution. Users should adapt templates accordingly.
11
Educational Use DisclaimerThese templates may be used for training, academic, or workflow optimization purposes but should be validated before use in real clinical environments.
12
Limitation of Liability DisclaimerThe creators of this content are not liable for any errors, omissions, or outcomes resulting from the use of these templates in clinical or administrative settings.
.png)
